Literature DB >> 19740297

Effect of captopril on pulmonary artery pressure following corrective surgery for tetralogy of fallot.

Zeng-Shan Ma1, Sheng-Jun Ma, Ming-Feng Dong, Jian-Tang Wang, Le-Xin Wang.   

Abstract

BACKGROUND: This study was designed to investigate the effect of captopril on systolic pulmonary arterial pressure (PAP) and circulating endothelin-1 (ET-1) following surgical repair of tetralogy of Fallot (TOF). METHODS AND
RESULTS: Seventy-six consecutive patients were divided into captopril and control groups following successful repair of TOF. The captopril group was treated with oral captopril (0.2 mg/kg/day) for 12 months. Venous blood was taken before and after the surgery for the analysis of ET-1. Systolic PAP and ventricular function were assessed by Doppler echocardiography. In the control group, there was an increase in ET-1 and systolic PAP following the surgery (p < 0.05). In the captopril group, there was no significant increase in the systolic PAP and ET-1 during the 12-month follow-up. The PAP and ET-1 values in the captopril group were lower than those in the control group following the surgery (p < 0.05).
CONCLUSIONS: Systolic PAP is elevated following the complete surgical repair of TOF. Increased circulating ET-1 may be responsible for the elevation of PAP. Captopril treatment prevents postsurgical increases in systolic PAP and circulating ET-1.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19740297     DOI: 10.1111/j.1540-8191.2009.00873.x

Source DB:  PubMed          Journal:  J Card Surg        ISSN: 0886-0440            Impact factor:   1.620


  5 in total

1.  The cause of B-type natriuretic peptide elevation and the dose-dependent effect of angiotensin-converting enzyme inhibitor on patients late after tetralogy of Fallot repair.

Authors:  Takuo Furukawa; Tomoaki Murakami; Michihiko Ueno; Atsuhito Takeda; Satoshi Yakuwa; Hirokuni Yamazawa
Journal:  Pediatr Cardiol       Date:  2011-09-30       Impact factor: 1.655

2.  Effect of prostaglandin E1 inhalation on pulmonary hypertension following corrective surgery for congenital heart disease.

Authors:  Chun-Yan Zhang; Zeng-Shan Ma; Long-Le Ma; Le-Xin Wang
Journal:  Exp Clin Cardiol       Date:  2013

3.  Atorvastatin improves endothelial progenitor cell function and reduces pulmonary hypertension in patients with chronic pulmonary heart disease.

Authors:  Hai-Feng Liu; Xue-Wen Qi; Long-le Ma; Dao-Kuo Yao; Lexin Wang
Journal:  Exp Clin Cardiol       Date:  2013

4.  Severe pulmonary artery hypertension following intracardiac repair of tetralogy of Fallot: An unusual finding.

Authors:  Bhupesh Kumar; Goverdhan D Puri; Rohit Manoj; Kirti Gupta; K S Shyam
Journal:  Pulm Circ       Date:  2011 Jan-Mar       Impact factor: 3.017

5.  Correlation between serum high-mobility group box-1 levels and high-sensitivity C-reactive protein and troponin I in patients with coronary artery disease.

Authors:  Heng-Chen Yao; Ai-Ping Zhao; Qian-Feng Han; Lei Wu; Dao-Kuo Yao; LE-Xin Wang
Journal:  Exp Ther Med       Date:  2013-04-30       Impact factor: 2.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.